Autoimmune Lung Disease Studies

​The Division of Rheumatology strives to understand more about autoimmune lung disease through research.  Please see the list below, which summarizes the studies available to individuals interested in advancing our understanding and treatment of rheumatic disease. 

Study Name/IRB#/PI	​Brief Description	Basic Eligibility Criteria​	Contact
STARS-ILD 25-1951 Melissa Griffith, MD	Observational study investigating the causes of Interstitial Lung Disease (ILD) in people with Rheumatoid Arthritis (RA) and Scleroderma (SSc).	Basic Eligibility - Confirmed diagnosis of RA or SSc, with or without ILD. - Willingness to take pulmonary function tests, sputum collection, and complete a CT scan.	RAStudies@cuanschutz.edu   303-724-7594 www.SlayRA.com

Please note that study status changes frequently and therefore, a listed study may not be actively enrolling. Also, the complete list of inclusion and exclusion criteria for a given study is often not listed due to its length.  A visit to determine an individuals eligibility may be required.  A placebo is an inactive substance or treatment that looks the same as, and is given the same way as, an active drug or treatment being tested. The effects of the active drug or treatment are compared to the effects of the placebo.​